Table 1

Response information, and smoking and accessibility prevalence in the study population, derived from the European Survey Project on Alcohol and Other Drugs survey (n=174 848), presented by country

Year of point-of-sale display ban implementationIndividual response rate (%)Respondents (N)Regular smoking prevalence* (weighted %)Easy accessibility of tobacco† (weighted %)
200720112015200720112015200720112015200720112015
Austria91–‡902362–‡324532.3–‡20.463.1–‡60.5
Belgium (Flanders)95959415941465146915.616.610.551.157.945.7
Bulgaria86828418121633223036.134.330.175.767.264.0
Croatia201389898926232505208728.732.027.265.159.653.4
Cyprus–‡828542253011146622.719.915.358.754.151.8
Czech Republic8989–‡36543534242326.327.318.162.464.154.0
Denmark8789–‡8321992148122.716.010.178.457.051.7
Estonia79829020382033195819.420.114.240.939.232.9
Finland201290899042663190333821.622.413.241.743.737.8
Greece91909223614162242216.917.313.765.156.251.7
Iceland200181818628692464212912.67.33.744.535.224.8
Ireland200994869419891964123714.811.27.246.341.929.5
Latvia8385852017224290730.029.317.348.647.538.2
Lithuania86898820092024198323.225.817.449.947.338.6
Malta84788331712802266013.511.37.646.240.034.6
Netherlands93–‡–‡17361624130024.923.014.865.567.350.3
Norway201089938930752479213911.15.22.149.742.46.1
Poland8482831839521010 42413.117.714.054.954.147.3
Portugal96919325711572258610.817.812.248.549.939.9
Romania84898415571777207820.222.624.243.533.241.7
Slovakia89828921551568179425.926.520.162.962.155.6
Slovenia86898826162578270622.922.013.366.255.940.0
Sweden84858629172280221610.612.97.249.949.338.9
Ukraine82838017211452154325.820.413.945.631.930.1
UK2012/20138481–‡20001487–‡13.914.6–‡52.139.6–‡
Total§87868760 00957 04857 82120.619.714.555.149.942.5
  • *Weighted % of respondents who reported smoking at least one cigarette per day in the last 30 days.

  •  †Weighted % of respondents perceiving very easy access to tobacco, smokers and non-smokers combined.

  • ‡Not available.

  • § Totals for smoking and accessibility represent the average weighted prevalence across countries, to which all countries contribute equally independent of population size.